WELL Health Technologies Corp. (TSE:WELL) Receives C$7.43 Average Target Price from Analysts

WELL Health Technologies Corp. (TSE:WELL) has earned a consensus recommendation of “Buy” from the six analysts that are currently covering the stock, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is C$7.43.

Separately, CIBC upgraded WELL Health Technologies from a “neutral” rating to an “outperform” rating in a research note on Wednesday, December 3rd.

WELL Health Technologies Price Performance

WELL stock opened at C$4.17 on Friday. The company has a debt-to-equity ratio of 46.79, a quick ratio of 1.02 and a current ratio of 1.14. The business has a 50-day simple moving average of C$3.99 and a two-hundred day simple moving average of C$4.57. The company has a market capitalization of C$1.06 billion, a P/E ratio of -46.33, a price-to-earnings-growth ratio of -1.93 and a beta of 0.86. WELL Health Technologies has a 52-week low of C$3.58 and a 52-week high of C$6.90.

WELL Health Technologies (TSE:WELL) last posted its earnings results on Thursday, November 6th. The company reported C$0.16 earnings per share for the quarter. The company had revenue of C$364.60 million for the quarter. WELL Health Technologies had a return on equity of 8.74% and a net margin of 7.67%. Research analysts expect that WELL Health Technologies will post 0.3000698 EPS for the current fiscal year.

WELL Health Technologies Company Profile

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services – Primary includes clinical operations and allied health. Omni-channel Patient Services – Specialized comprises CRH and MyHealth under two segments.